RxDoctor Payments Data

Ernest Miller, MD

Psychiatry · Gibson City, ILNPI 1922666429

Payments from drug & device makers

$1,447in general payments, 2019–2025

Across 33 payments — averaging $43.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$499
  • Johnson & Johnson$275
  • Alkermes, Inc.$212
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$180
  • Teva Pharmaceuticals USA, Inc.$148
  • AbbVie$42
  • plus $90 from 3 others

What the payments were for

  • Food & beverage$1,447100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,447 in reported general payments places this provider in the 75th percentile of 1,344 psychiatry providers in Illinois.

See all psychiatry providers in Illinois

Medicare billing

Part B allowed, 2024
$4,336
Medicare patients
17
Services billed
34

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AristadaAripiprazole Lauroxil15$47,671
Invega SustennaPaliperidone Palmitate13$32,291
VraylarCariprazine Hcl18$24,815
Carbamazepine ErCarbamazepine19$1,567
Divalproex Sodium ErDivalproex Sodium32$1,267
Clozapine27$1,146
Duloxetine Hcl46$788
Bupropion XlBupropion Hcl24$705
Olanzapine53$692
Divalproex Sodium16$667
Oxcarbazepine12$438
Quetiapine Fumarate18$402
Guanfacine Hcl ErGuanfacine Hcl13$368
Hydroxyzine Hcl25$346
Buspirone Hcl30$308

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Alkermes, Inc.Aristada$212$47,67115 claims
Johnson & JohnsonInvega Sustenna$275$32,29113 claims
AbbVieVraylar$42$24,81518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,344 psychiatry providers in Illinois.

Other psychiatry in Gibson City

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →